Close
Nordic 9Nordic 9

Cytovac (private company)

Denmark cytovac.com
See something wrong or missing? Let us know
Offices:Hørsholm
Industry:Biotech
Business model:B2B

Cytovac is a Danish biotech company, which has chosen to focus on development of a cancer treatment that uses the body’s own immune system.

values in USD

Investments 2.24M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Cytovac

Name Criteria
France AbolerIS Pharma
28%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark Acesion Pharma
28%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway Age Labs AS
28%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway APIM Therapeutics
28%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Spain AptaTargets
28%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Athera
28%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden AttgeNO
28%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
France BeFC
28%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Better Dairy
28%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Norway Bio-Me
28%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Top